Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Ghent
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically proven and unresectable adenocarcinoma of the pancreas or cholangiocarcinoma with no evidence of metastatic disease
WHO performance status of 0 or 1
Complete recovrey from surgery in case an enteric and/or biliary tract by-pass operation has been performed
Maximum delay after surgery: 8 weeks
No previous or co-existent malignant disease except non melanoma skin cancers and adequately treated cervic carcinoma in situ
Adequate bon marrow reserve
No previous chemotherapy or radiotherapy
Expected survival \> 6 months
You may not be if
Active infection
Metastatic disease
Inadequate liver function after derivative surgery
Inadequate renal function
Pregnancy, breast feeding
Use of any other investigational agent in the month before enrollment
Patients with grade 2 or more neuropathy
Clareo Health | Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma
